Posted in Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, Equipments, Gels, Isotypes, NATtrol, Panel, Pcr Kits, Peptides, Reagents, Recombinant Proteins
The APHIRM toolkit: an evidence-based system for workplace MSD risk management.
Musculoskeletal Disorders (MSDS) continues as one of the biggest health and safety issues throughout the world. One reason for this situation is that risk management practices at work are currently failing to meet several important evidence-based requirements for effective MSD risk reduction. In particular: they have mostly failed to overcome the risks arising from psychosocial hazards; Don’t let adequate participation by workers; And often fail to control the risk of the source.
To overcome this deficiency, the participatory hazard identification tool (Ahirm) has been formulated in accordance with the two frameworks developed by the principles of world health and science science. It consists of a set of online tools that include automatic data analysis and reporting modules, and procedures for guiding users through five conventional risk management cycles. Important, this assesses the level of danger and risk for groups of people who do certain jobs, focusing on overall work than only on tasks that are considered dangerous.
The intended user is the workplace manager and consultant responsible for the health and safety of work, with active participation as well as workers. Resulted risk control interventions are adjusted to overcome the main physical and psychosocial hazards identified for target work, and repetition of risk management cycles allow evaluation of sustainable results in terms of danger and risk.
Identification of gender differences in factors that influence the shoulder, neck and top of the MSD limb using the Multivariate Adaptive Regression Splines (Mars).
In this study, the model based on the multivariate adaptive regression splines (Mars) was proposed to study gender influences in factors that influence the development of shoulder, neck and legs over MSD. Two different Mars models, according to men and women, are built to identify variables with the strongest effects on MSD targets. Both models are able to predict the success of the occurrence of disorders learned.
Men seem to be more susceptible to physical risk factors and some other working conditions, while women seem to be more affected by psychosocial risk factors and activities carried out outside their working hours. According to the results, gender needs to be considered to ensure the success and effectiveness of ergonomic intervention in all worker populations.
Exploring CPGs is specialized in diseases in the human male genital abnormality using MSD-AFLP.
The incidence of male reproductive system disorders, especially hypospadia, has increased in developed countries since the second half of the 20th century. Chemicals that disrupt endocrine from the environment are considered involved in hypospadia onset through epigenetic changes. This pilot study aims to explore the CPG specific methylation of the disease in the patient’s sample exhibited with metyl). We compare clinical samples from hypospadia and phimosis patients.

Blood foreskin and sample were collected from patients one to two years with hypospadia (n = 3) and phimosis (n = 3) during surgical care. MSD-AFLP analysis shows a significant decrease in CPG methylation gene levels such as MyH11 and an increase in the level of CPG methylation gene such as PLA2G15 in hypospadia patients. Analysis of hierarchical grouping shows that genes with CPG levels that change significantly are significantly changed in DNA from the blood than from the skin of the earth. Because a small number of samples, further investigations are needed to explain the relationship between variations on CPG levels on bloodshed and blood DNA and male genital abnormalities.
In the MSD-ѱ generation of HIV provincial classes damaged.
Antiretroviral therapy (ART) can effectively reduce sustainable HIV replication and block the development of the disease, but infections have never been cured due to the persistence of small collection of infected cells with latent, provirus HIV competent replication. However, most of the HIV provirus in patients treated with art is incompetent replication because of various genetic defects. Most of the provirus damaged (around 90%) contains large internal removal or G-to-A hypermutation, produces most destruction if not all viral open reading frames, which are consistent with the idea that cytotoxic cell (CTLS) removes cells effectively , which produces viral antigens.
The interesting subclass of the disabled provirus (around 10%) which is consistently detected in these patients brings small removal or mutation of points in a relatively right area and is preserved near 5 ‘HIV genome tip, in the area that encodes the Major Splice Donor site (MSD ) And the packaging signal ѱ in the virus RNA genome. Why this subceRim provirus is damaged it has never been well understood. We now propose a mechanistic scenario for how MSD-ѱ mutations can prevent viral protein expressions. Based on sufficient results in the literature, we argue that MSD’s inactivation triggers the activities of 5’-polyiadenilation sites, resulting in production of Ultra-short non-protein-coding HIV transcripts.
Measurement of IL-21 in serum and human plasma use the ultrasensitive methodology of MSD S-Plex® and Quantierix Simoa.
IL-21 is a pleiotropic cytokine that plays a key role in modulating inflammatory responses, including autoimmune disease promotion. Some groups have reached the level of IL-21 circuits in plasma and serum samples using various commercial elisa. We are determined, however, that the most commonly used commercial tests in published literature are not specific or sensitive to detect IL-21 levels in heparin plasma or serum from healthy human individuals. These findings encourage efforts to develop more specific and sensitive methods to measure IL-21 in a complex biological matrix using anti-IL-21 antibodies belonging to the Quantierix Simoa platform and the S-Plex® S-Plex® Meso S-PLEX® format (MSD).
Anti-LAMP3 antibody (Alexa-fluor 488) |
STJ170004 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
Anti-IL3RA antibody (Alexa-fluor 488) |
STJ170009 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
Anti-CD207 antibody (Alexa-fluor 488) |
STJ170014 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
Anti-IL7R antibody (Alexa-fluor 488) |
STJ170020 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
Goat anti Mouse IgG1 (Alexa Fluor 488) |
43R-1649 |
Fitzgerald |
500 ug |
EUR 570 |
Description: Goat anti Mouse IgG1 secondary antibody (Alexa Fluor 488) |
Anti-Hu CD16 Alexa Fluor® 488 |
A4-646-T100 |
ExBio |
100 tests |
EUR 269 |
AF488 Phalloidin [equivalent to Alexa Fluor® 488 phalloidin] |
23153 |
AAT Bioquest |
300 Tests |
EUR 306 |
- R-phrase: R23, R24, R25
- H-Phrase: H301, H311, H331
- Symbol for dangerous compounds: T
- UNSPEC Code: 12352200
|
AF488-streptavidin conjugate [Streptavidin, Alexa Fluor™ 488 Conjugate] |
16891 |
AAT Bioquest |
1 mg |
EUR 176 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Anti-Hu CD72 Alexa Fluor® 488 |
A4-310-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Bov CD9 Alexa Fluor® 488 |
A4-354-C100 |
ExBio |
0.1 mg |
EUR 269 |
Endoglin/CD105 Alexa Fluor |
FC15024 |
Neuromics |
100 Tests |
EUR 448 |
Goat Anti-Mouse IgG(H+L) Alexa Fluor 488–conjugated |
S0017 |
Affbiotech |
200ul |
EUR 304 |
Goat Anti-Rabbit IgG(H+L) Alexa Fluor 488–conjugated |
S0018 |
Affbiotech |
200ul |
EUR 304 |
Donkey Anti-Rabbit IgG (H+L), Alexa Fluor® 488 Conjugated |
Ab8032-001 |
GenDepot |
0.5mg |
EUR 435 |
Anti-Hu CD3 zeta (pY153) Alexa Fluor® 488 |
A4-686-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD3 zeta (pY72) Alexa Fluor® 488 |
A4-712-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD3 zeta (pY142) Alexa Fluor® 488 |
A4-730-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD3 zeta (pY111) Alexa Fluor® 488 |
A4-737-C100 |
ExBio |
0.1 mg |
EUR 269 |
SAM FCM (Alexa Fluor 647) |
abx098902-100tests |
Abbexa |
100 tests |
EUR 1233 |
- Shipped within 5-10 working days.
|
Anti-LAMP3 (human) Monoclonal Antibody (104G4) (Alexa Fluor® 488) |
M09406 |
BosterBio |
100ug |
EUR 565 |
Description: Mouse Monoclonal LAMP3 (human) Antibody (104G4) (Alexa Fluor® 488). Validated in IHC and tested in Human. |
Alpha Fluor™ 488 amine |
1705 |
AAT Bioquest |
1 mg |
EUR 306 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Alpha Fluor™ 488 Hydroxylamine |
1900 |
AAT Bioquest |
1 mg |
EUR 306 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Anti-LAMP3 antibody (Alexa-fluor 546) |
STJ170005 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
Anti-LAMP3 antibody (Alexa-fluor 647) |
STJ170006 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
Anti-IL3RA antibody (Alexa-fluor 546) |
STJ170010 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
Anti-IL3RA antibody (Alexa-fluor 647) |
STJ170011 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
Anti-CD207 antibody (Alexa-fluor 546) |
STJ170015 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
Anti-CD207 antibody (Alexa-fluor 647) |
STJ170016 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
Anti-IL7R antibody (Alexa-fluor 546) |
STJ170021 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
Anti-IL7R antibody (Alexa-fluor 647) |
STJ170022 |
St John's Laboratory |
100 µg |
EUR 393 |
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
Anti-Langerin (human) Monoclonal Antibody (DCGM4/122D5) (Alexa Fluor® 488) |
M02316 |
BosterBio |
100ug |
EUR 580 |
Description: Mouse Monoclonal Langerin (human) Antibody (DCGM4/122D5) (Alexa Fluor® 488). Validated in IHC and tested in Human. |
Alpha Fluor™ 488 NHS Ester |
1812 |
AAT Bioquest |
1 mg |
EUR 219 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Streptavidin-Alexa488 (Alexas fluor 488) conjugate |
SV-A488-100 |
Alpha Diagnostics |
100 tests |
EUR 225 |
Rabbit Anti-Rat IgG (H+L)-Alexa 488 Fluor conjugate (adsorbed with human IgG) |
50336 |
Alpha Diagnostics |
0.5 ml |
EUR 225 |
Alpha Fluor™ 532 acid [equivalent to Alexa Fluor™ 532 acid] |
1795 |
AAT Bioquest |
10 mg |
EUR 393 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Mouse IgG1-Alexa 488 conjugate (isotype control) |
20102-101-A488 |
Alpha Diagnostics |
50 Tests |
EUR 263 |
AF350 Phalloidin [equivalent to Alexa Fluor® 350 phalloidin] |
23150 |
AAT Bioquest |
300 Tests |
EUR 306 |
- R-phrase: R23, R24, R25
- H-Phrase: H301, H311, H331
- Symbol for dangerous compounds: T
- UNSPEC Code: 12352200
|
AF594 Phalloidin [equivalent to Alexa Fluor® 594 phalloidin] |
23158 |
AAT Bioquest |
300 Tests |
EUR 306 |
- R-phrase: R23, R24, R25
- H-Phrase: H301, H311, H331
- Symbol for dangerous compounds: T
- UNSPEC Code: 12352200
|
AF350-streptavidin conjugate [Streptavidin, Alexa Fluor™ 350 Conjugate] |
16890 |
AAT Bioquest |
1 mg |
EUR 176 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
AF594-streptavidin conjugate [Streptavidin, Alexa Fluor™ 594 Conjugate] |
16892 |
AAT Bioquest |
1 mg |
EUR 176 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Donkey anti Goat IgG (H + L) (Alexa Fluor 594) |
43R-ID005AF |
Fitzgerald |
500 ug |
EUR 338 |
Description: Donkey anti Goat IgG (H + L) secondary antibody (Alexa Fluor 594) |
Donkey anti Rat IgG (H + L) (Alexa Fluor 594) |
43R-ID022AF |
Fitzgerald |
500 ug |
EUR 364 |
Description: Donkey anti Rat IgG (H + L) secondary antibody (Alexa Fluor 594) |
Donkey anti Goat IgG (H + L) (Alexa Fluor 647) |
43R-ID028AF |
Fitzgerald |
500 ug |
EUR 430 |
Description: Donkey anti Goat IgG (H + L) secondary antibody (Alexa Fluor 647) |
Donkey anti Rat IgG (H + L) (Alexa Fluor 594) |
43R-ID047AF |
Fitzgerald |
500 ug |
EUR 462 |
Description: Donkey anti Rat IgG (H + L) secondary antibody (Alexa Fluor 594) |
Donkey anti Chicken IgY (H + L) (Alexa Fluor 594) |
43R-ID056AF |
Fitzgerald |
500 ug |
EUR 343 |
Description: Donkey anti Chicken IgY secondary antibody (H + L) (Alexa Fluor 594) |
Donkey anti Chicken IgY (H + L) (Alexa Fluor 647) |
43R-ID060AF |
Fitzgerald |
300 ug |
EUR 425 |
Description: Donkey anti Chicken IgY (H + L) (Fab'2) (Alexa Fluor 647) |
Rabbit anti Chicken IgY (H + L) (Alexa Fluor 594) |
43R-IR016AF |
Fitzgerald |
1 mg |
EUR 281 |
Description: Rabbit anti Chicken IgY (H + L) secondary antibody (Alexa Fluor 594) |
Anti-Hu CD30 Alexa Fluor® 700 |
A7-455-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD94 Alexa Fluor® 700 |
A7-727-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD56 Alexa Fluor® 700 |
A7-789-T100 |
ExBio |
100 tests |
EUR 269 |
Goat Anti-Mouse IgG(H+L) Alexa Fluor 594–conjugated |
S0005 |
Affbiotech |
200ul |
EUR 376 |
Goat Anti-Rabbit IgG(H+L) Alexa Fluor 594–conjugated |
S0006 |
Affbiotech |
200ul |
EUR 376 |
Goat Anti-Rabbit IgG(H+L) Alexa Fluor 647–conjugated |
S0013 |
Affbiotech |
200ul |
EUR 304 |
Goat Anti-Mouse IgG(H+L) Alexa Fluor 647–conjugated |
S0014 |
Affbiotech |
200ul |
EUR 304 |
Mouse pre-microRNA Expression Construct mir-488 |
MMIR-488-PA-1 |
SBI |
Bacterial Streak |
EUR 684 |
|
Donkey anti Goat IgG (H + L) (Fab 2) (Alexa Fluor 594) |
43R-ID012AF |
Fitzgerald |
300 ug |
EUR 410 |
Description: Donkey anti Goat IgG (H + L) secondary antibody (Fab'2) (Alexa Fluor 594) |
Donkey Anti-Goat IgG (H+L), Alexa Fluor® 594 Conjugated |
Ab8011-001 |
GenDepot |
1mg |
EUR 334 |
Anti-Hu CD3 zeta (pY153) Alexa Fluor® 647 |
A6-686-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD3 zeta (pY72) Alexa Fluor® 647 |
A6-712-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD3 zeta (pY142) Alexa Fluor® 647 |
A6-730-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD3 zeta (pY111) Alexa Fluor® 647 |
A6-737-C100 |
ExBio |
0.1 mg |
EUR 269 |
Rabbit Anti-Rat IgG (H+L)-Alexa 594 Fluor conjugate (adsorbed with human IgG) |
50337 |
Alpha Diagnostics |
0.5 ml |
EUR 225 |
Recombinant (E.Coli) Hepatitis C Virus (HCV) NS5 Genotype-2a |
RP-488 |
Alpha Diagnostics |
100 ug |
EUR 286 |
Tide Fluor 2-LL-37 |
H-8286.0100 |
Bachem |
0.1mg |
EUR 312 |
Description: Sum Formula: C205H340N60O53+dye |
Tide Fluor 2-LL-37 |
H-8286.0500 |
Bachem |
0.5mg |
EUR 1017 |
Description: Sum Formula: C205H340N60O53+dye |
Anti-Cytokeratins Alexa Fluor488 |
A4-108-C025 |
ExBio |
0.025 mg |
EUR 175 |
Anti-Cytokeratins Alexa Fluor488 |
A4-108-C100 |
ExBio |
0.1 mg |
EUR 310 |
Anti-PSMA Alexa Fluor488 |
A4-539-C025 |
ExBio |
0.025 mg |
EUR 227 |
Anti-PSMA Alexa Fluor488 |
A4-539-C100 |
ExBio |
0.1 mg |
EUR 414 |
Anti-FoxP3 Alexa Fluor488 |
A4-601-C025 |
ExBio |
0.025 mg |
EUR 201 |
Anti-FoxP3 Alexa Fluor488 |
A4-601-C100 |
ExBio |
0.1 mg |
EUR 362 |
Anti-Phosphotyrosine Alexa Fluor647 |
A6-263-C025 |
ExBio |
0.025 mg |
EUR 154 |
Anti-Phosphotyrosine Alexa Fluor647 |
A6-263-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-LCK Alexa Fluor647 |
A6-269-C025 |
ExBio |
0.025 mg |
EUR 206 |
Anti-LCK Alexa Fluor647 |
A6-269-C100 |
ExBio |
0.1 mg |
EUR 373 |
Anti-FoxP3 Alexa Fluor647 |
A6-601-C025 |
ExBio |
0.025 mg |
EUR 201 |
Anti-FoxP3 Alexa Fluor647 |
A6-601-C100 |
ExBio |
0.1 mg |
EUR 362 |
Monoclonal Anti-Monkey IgG-Alexa 488 Conj. (specific for monkey; no reactivity with human or animals IgG) |
70030-AF488 |
Alpha Diagnostics |
50 tests |
EUR 347 |
CellBriteâ„¢ Fix 488 |
30090 |
Biotium |
1KIT |
EUR 644 |
Description: Minimum order quantity: 1 unit of 1KIT |
Metal Fluor™ Zn-520, AM |
21263 |
AAT Bioquest |
1 mg |
EUR 219 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12352200
|
Alpha Fluor™ 532 NHS Ester |
1819 |
AAT Bioquest |
1 mg |
EUR 219 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Alpha Fluor™ 594 C5 Maleimide |
1891 |
AAT Bioquest |
1 mg |
EUR 219 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Helix Fluor™ 6-JOE Phosphoramidite |
6046 |
AAT Bioquest |
100 umoles |
EUR 50 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 12171501
|
Tide Fluor 2-LL-37 (scrambled) |
H-8288.0100 |
Bachem |
0.1mg |
EUR 312 |
Description: Sum Formula: C205H340N60O53+dye |
Tide Fluor 2-LL-37 (scrambled) |
H-8288.0500 |
Bachem |
0.5mg |
EUR 1017 |
Description: Sum Formula: C205H340N60O53+dye |
Tide Fluor 5WS-o-Conotoxin GVIA |
H-8356.0100 |
Bachem |
0.1mg |
EUR 1146 |
Description: Sum Formula: C120H182N38O43S6+dye |
Streptavidin-Alexa594 (Alexas fluor 594) conjugate |
SV-A594-100 |
Alpha Diagnostics |
100 tests |
EUR 225 |
Anti-Cytokeratin 18 Alexa Fluor488 |
A4-106-C025 |
ExBio |
0.025 mg |
EUR 186 |
Anti-Cytokeratin 18 Alexa Fluor488 |
A4-106-C100 |
ExBio |
0.1 mg |
EUR 331 |
Anti-Cytokeratin 19 Alexa Fluor488 |
A4-120-C025 |
ExBio |
0.025 mg |
EUR 186 |
Anti-Cytokeratin 19 Alexa Fluor488 |
A4-120-C100 |
ExBio |
0.1 mg |
EUR 331 |
Anti-Ki-67 Alexa Fluor488 |
A4-155-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Ki-67 Alexa Fluor488 |
A4-155-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD45 Alexa Fluor488 |
A4-160-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD193 Alexa Fluor488 |
A4-161-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD279 Alexa Fluor488 |
A4-176-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD43 Alexa Fluor488 |
A4-220-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD43 Alexa Fluor488 |
A4-220-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD44 Alexa Fluor488 |
A4-221-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD44 Alexa Fluor488 |
A4-221-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD45 Alexa Fluor488 |
A4-222-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD45 Alexa Fluor488 |
A4-222-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD55 Alexa Fluor488 |
A4-230-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD55 Alexa Fluor488 |
A4-230-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD50 Alexa Fluor488 |
A4-266-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD50 Alexa Fluor488 |
A4-266-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD31 Alexa Fluor488 |
A4-273-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD31 Alexa Fluor488 |
A4-273-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD147 Alexa Fluor488 |
A4-274-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD147 Alexa Fluor488 |
A4-274-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD34 Alexa Fluor488 |
A4-297-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD34 Alexa Fluor488 |
A4-297-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD105 Alexa Fluor488 |
A4-298-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD105 Alexa Fluor488 |
A4-298-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD41 Alexa Fluor488 |
A4-309-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD41 Alexa Fluor488 |
A4-309-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD72 Alexa Fluor488 |
A4-310-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD63 Alexa Fluor488 |
A4-343-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD63 Alexa Fluor488 |
A4-343-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD13 Alexa Fluor488 |
A4-396-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD13 Alexa Fluor488 |
A4-396-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-HLA-G Alexa Fluor488 |
A4-431-C025 |
ExBio |
0.025 mg |
EUR 217 |
Anti-HLA-G Alexa Fluor488 |
A4-431-C100 |
ExBio |
0.1 mg |
EUR 394 |
Anti-HLA-G Alexa Fluor488 |
A4-437-C025 |
ExBio |
0.025 mg |
EUR 217 |
Anti-HLA-G Alexa Fluor488 |
A4-437-C100 |
ExBio |
0.1 mg |
EUR 394 |
Anti-Hu CD300a Alexa Fluor488 |
A4-501-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-HLA-A2 Alexa Fluor488 |
A4-556-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-HLA-A2 Alexa Fluor488 |
A4-556-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-CD3 zeta Alexa Fluor488 |
A4-568-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Ms CD8a Alexa Fluor488 |
A4-579-C025 |
ExBio |
0.025 mg |
EUR 139 |
Anti-Ms CD8a Alexa Fluor488 |
A4-579-C100 |
ExBio |
0.1 mg |
EUR 238 |
Anti-Hu CD326 Alexa Fluor488 |
A4-582-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD3 Alexa Fluor488 |
A4-631-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD16 Alexa Fluor488 |
A4-646-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD150 Alexa Fluor488 |
A4-660-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD107a Alexa Fluor488 |
A4-671-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD107a Alexa Fluor488 |
A4-671-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD107b Alexa Fluor488 |
A4-672-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD107b Alexa Fluor488 |
A4-672-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD73 Alexa Fluor488 |
A4-675-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD11b Alexa Fluor488 |
A4-681-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD11b Alexa Fluor488 |
A4-681-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD35 Alexa Fluor488 |
A4-703-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD305 Alexa Fluor488 |
A4-713-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD161 Alexa Fluor488 |
A4-729-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD144 Alexa Fluor488 |
A4-770-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-HLA-ABCE Alexa Fluor488 |
A4-813-C100 |
ExBio |
0.1 mg |
EUR 373 |
Anti-Ki-67 Alexa Fluor647 |
A6-155-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Ki-67 Alexa Fluor647 |
A6-155-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD45 Alexa Fluor647 |
A6-160-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD193 Alexa Fluor647 |
A6-161-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD279 Alexa Fluor647 |
A6-176-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD273 Alexa Fluor647 |
A6-178-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD231 Alexa Fluor647 |
A6-200-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD9 Alexa Fluor647 |
A6-208-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD9 Alexa Fluor647 |
A6-208-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD45 Alexa Fluor647 |
A6-222-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD45 Alexa Fluor647 |
A6-222-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD45RB Alexa Fluor647 |
A6-224-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD45RB Alexa Fluor647 |
A6-224-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD55 Alexa Fluor647 |
A6-230-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD55 Alexa Fluor647 |
A6-230-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD59 Alexa Fluor647 |
A6-233-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD59 Alexa Fluor647 |
A6-233-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD71 Alexa Fluor647 |
A6-235-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD71 Alexa Fluor647 |
A6-235-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD21 Alexa Fluor647 |
A6-306-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD21 Alexa Fluor647 |
A6-306-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD177 Alexa Fluor647 |
A6-314-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD177 Alexa Fluor647 |
A6-314-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD222 Alexa Fluor647 |
A6-315-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD222 Alexa Fluor647 |
A6-315-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD30 Alexa Fluor647 |
A6-455-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD30 Alexa Fluor647 |
A6-455-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-gamma-Tubulin Alexa Fluor647 |
A6-465-C025 |
ExBio |
0.025 mg |
EUR 217 |
Anti-gamma-Tubulin Alexa Fluor647 |
A6-465-C100 |
ExBio |
0.1 mg |
EUR 394 |
Anti-Hu CD264 Alexa Fluor647 |
A6-519-C100 |
ExBio |
0.1 mg |
EUR 269 |
Anti-Hu CD69 Alexa Fluor647 |
A6-552-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD69 Alexa Fluor647 |
A6-552-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-HLA-A2 Alexa Fluor647 |
A6-556-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-HLA-A2 Alexa Fluor647 |
A6-556-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD326 Alexa Fluor647 |
A6-581-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD326 Alexa Fluor647 |
A6-581-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD326 Alexa Fluor647 |
A6-582-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD158d Alexa Fluor647 |
A6-609-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD3 Alexa Fluor647 |
A6-631-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD209 Alexa Fluor647 |
A6-640-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD64 Alexa Fluor647 |
A6-644-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD64 Alexa Fluor647 |
A6-644-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD16 Alexa Fluor647 |
A6-646-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD16 Alexa Fluor647 |
A6-646-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD150 Alexa Fluor647 |
A6-660-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD73 Alexa Fluor647 |
A6-675-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-HLA-DR Alexa Fluor647 |
A6-690-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-HLA-DR Alexa Fluor647 |
A6-690-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD161 Alexa Fluor647 |
A6-729-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD200 Alexa Fluor647 |
A6-746-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD160 Alexa Fluor647 |
A6-750-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD243 Alexa Fluor647 |
A6-764-T100 |
ExBio |
100 tests |
EUR 269 |
The testing developed on both technology platforms was characterized in the plasma heparin and serum using a recovery of surge in various concentrations. Each method can detect sub-pg / ml IL-21 levels (Detection Prediction limit of [LOD] around 1.0 FG / mL for the QuantiX Simoa and MSD S-Plex® platform) which is 200-500 times lower than the current commercial test ,